Genetic Testing Travel 2026: Macrogen vs BGI vs Centogene vs US (Invitae, Nebula) Comparison

Your sister got the Invitae Cancer panel for $349 with US insurance and learned she carries a BRCA2 variant that changes her preventive screening for life. Your colleague flew to Seoul, paid Macrogen $620 for 30x whole-genome sequencing, and received her raw data file four weeks later with no insurance middleman involved. You read about BGI in Hong Kong offering WGS around $300-$400 per sample and got nervous about where that data would live long-term. Your friend's genetic counselor told her that GINA (the Genetic Information Nondiscrimination Act) protects her from health insurance discrimination based on genetic results but offers zero protection against life insurance, disability insurance, or long-term-care underwriting. And now you are sitting with a quote from a US lab for $2,200 in whole-genome sequencing wondering whether to pay it, travel to Korea, or just hold off entirely.

This guide gives you the actual 2026 genetic testing tourism landscape. Real per-lab costs and turnaround times. Real GINA coverage limits. Real data sovereignty considerations. Real US clinical interpretation requirements. Travel Anywhere is the AI-powered travel planning platform at travelanywhere.chat that helps travelers like you plan medical tourism trips, book around clinical lab schedules, and understand exactly what they are paying for before they land.

TL;DR: US whole-genome sequencing (WGS) runs $1,500-$3,000 through major domestic providers. International labs offer significant savings: Macrogen (Korea) $400-$800 at 30x coverage, BGI Genomics (Hong Kong) $300-$600 for research-grade WGS, Centogene (Germany) $1,200-$2,500 for rare-disease diagnostic WGS with clinical interpretation. GINA protects health insurance only. Life insurance, disability insurance, and long-term-care insurance are not covered by GINA, meaning insurers in those categories can legally use your genetic results in underwriting decisions. International sequencing may reduce US legal discovery exposure in disputes, but does not remove this underwriting risk. Raw data ownership, GDPR-class protections (EU labs), and China data security law (BGI) are the core data sovereignty questions to resolve before you book.

Key Takeaways

• WGS at US labs runs $1,500-$3,000 out-of-pocket. Macrogen in Korea offers 30x WGS for $400-$800 with a 4-6 week turnaround and raw data delivery; BGI Genomics in Hong Kong offers research-grade WGS starting around $300-$400 per sample but is structured for institutional buyers rather than walk-in consumers.
• GINA covers health insurance discrimination only. Life, disability, and long-term-care insurers are legally permitted to use your genetic test results in coverage and premium decisions under current US federal law, regardless of whether your testing was done domestically or internationally.
• International testing does not erase underwriting risk. If you disclose international genetic results to a US life insurer on an application, those results can be used against you. The protection gap is about the insurance product category, not about where the sequencing happened.
• Data sovereignty varies sharply by jurisdiction. Centogene (Germany) operates under GDPR. BGI Genomics (Hong Kong/China) is subject to China's Data Security Law and Personal Information Protection Law. Macrogen (Korea) operates under Korea's Personal Information Protection Act. US labs are governed by HIPAA plus state-level genomic data privacy laws (California CMIA, Texas, Illinois).
• Raw data portability is the most underrated factor. Macrogen delivers raw FASTQ files plus VCF variant files directly to the customer. Some US direct-to-consumer labs retain sequence data and restrict raw file exports. Confirm raw-file delivery in writing before you pay.
• A US genetic counselor review of any internationally obtained results is strongly recommended before acting on findings. The American College of Medical Genetics and Genomics (ACMG) publishes variant classification standards; US-licensed genetic counselors interpret results under those frameworks and are essential for translating international lab reports into US clinical decisions.

Full-body MRI travel 2026: Prenuvo, Ezra, and international alternatives compared

What Does Genetic Testing Tourism Actually Mean?

Genetic testing tourism is traveling to access sequencing services that are cheaper, faster, less restricted by insurance authorization, or more comprehensive than what is available domestically. It is a sub-niche of the broader medical tourism category, and it operates differently from other medical travel because you are not purchasing a procedure performed on-site at a foreign hospital. You are purchasing a laboratory analysis service.

The actual process typically works like this: you mail a blood or saliva sample (or arrange a blood draw in-country), the lab sequences your genome, and results come back digitally. Many travelers never physically visit the lab. What makes this "travel" is either a deliberate trip to submit a sample in person, or a planning decision about which country's lab to use, which is itself a travel-adjacent decision with real legal and financial consequences.

The six-tier landscape of 2026 genetic testing ranges from ancestry panels at $100-$200 (23andMe, MyHeritage) up to clinical whole-genome sequencing at $1,500-$3,000 domestically. The meaningful travel decision lives in the upper tiers: pharmacogenomics panels, hereditary cancer panels, whole-exome sequencing (WES), and whole-genome sequencing (WGS).

What Do US Labs Charge, and What Do You Get?

Understanding domestic pricing is the necessary baseline before evaluating international alternatives.

Photo by National Cancer Institute on Unsplash

Invitae (now operating through Labcorp following a 2024 acquisition) offers hereditary cancer panels for $249-$349 with insurance and $350-$500 without. Multi-gene panels covering BRCA1/2, Lynch syndrome genes, and cardiovascular hereditary conditions are in this range. Invitae's clinical interpretation is their core value: results include variant classification (pathogenic, likely pathogenic, variant of uncertain significance, benign) under ACMG standards, plus genetic counselor report language physicians can act on directly.

Color Health (now Color/Quest following the Quest Diagnostics partnership) offers hereditary cancer panels around $249-$350 and pharmacogenomics panels around $299. Their strength is integration with employer health plans and physician ordering workflows.

Sequencing.com (the most direct active successor to Nebula Genomics, which shut down in February 2025) offers 30x WGS at approximately $299-$499 with raw file delivery. Note that Nebula Genomics, which had operated a 100x ultra-deep WGS service priced around $650-$899, ceased consumer operations in February 2025. Sequencing.com is the closest current alternative at a similar price tier.

Hospital-based whole-genome sequencing at major academic medical centers runs $1,500-$3,000 for clinical-grade sequencing with full physician interpretation, and is typically ordered in the context of a diagnostic workup for a specific condition rather than for general wellness purposes.

How Much Does Macrogen Charge for WGS, and Is It Trustworthy?

Macrogen, headquartered in Seoul, Korea, is one of the highest-volume clinical and research sequencing labs in Asia. They operate dedicated consumer-facing sequencing services through Macrogen Europe and their Singapore platform.

Photo by National Cancer Institute on Unsplash

Pricing: Macrogen's 30x whole-genome sequencing runs approximately $400-$800 depending on the tier selected, data delivery speed, and whether bioinformatics analysis is included. Rush turnaround options (10-14 business days) carry a premium over standard turnaround (4-6 weeks). Research-grade sequencing without clinical interpretation sits at the lower end of this range; adding annotated variant reports or population comparison analysis pushes toward the upper end.

What you receive: Raw FASTQ sequencing files, aligned BAM files, and VCF variant files. Macrogen delivers raw data directly to the customer, which is a meaningful differentiator from US DTC labs that restrict file exports. This data is transferable to any US genetic counselor or physician for interpretation.

Turnaround: Standard 30x WGS is typically 4-6 weeks from sample receipt. Macrogen's European operation (based in Madrid with collection points across Europe) runs similar timelines. Turnaround communication is available in English and includes milestone notifications.

Quality: Macrogen uses Illumina sequencing platforms and is ISO 9001 certified. Their research-grade services are widely published in peer-reviewed genomics literature. For clinical-grade sequencing requiring CAP/CLIA accreditation (required for US clinical use), verify which specific service and laboratory location you are using. Research-grade data from Macrogen is scientifically valid; clinical-grade US interpretation still requires a US-licensed genetic counselor or physician.

Data privacy: Macrogen operates under Korea's Personal Information Protection Act (PIPA), which is considered GDPR-comparable in stringency. They do not share genomic data with third parties without explicit consent, and customers retain data deletion rights.

What Does BGI Genomics Actually Offer, and Should the Data Location Concern You?

BGI Genomics (BGI Group), headquartered in Shenzhen with major operations in Hong Kong, is the world's largest genomics company by sequencing volume. They offer some of the lowest-priced WGS on the market.

Pricing: BGI's research-grade human WGS starts around $300-$400 per sample for institutional buyers. Their most publicly visible consumer offer has been in the $400/sample range through services.bgi.com. BGI has historically positioned toward research institutions, hospitals, and government health programs rather than individual consumers, which means pricing for individual consumers may require a direct quote.

What you receive: Similar data outputs to Macrogen: raw FASTQ files plus processed VCF files. BGI uses their own DNBSEQ sequencing platform rather than Illumina, which produces data files compatible with standard bioinformatics tools but is worth confirming with any downstream US analysis service.

The data sovereignty question: This is the genuine concern that every independent genetic privacy researcher flags about BGI. BGI operates under China's Data Security Law (DSL, 2021) and Personal Information Protection Law (PIPL, 2021), both of which require cooperation with Chinese government data requests in ways that are materially different from GDPR or HIPAA protections. The US government has placed certain BGI affiliates on the Entity List over national security concerns related to genomic data collection at scale. This does not mean BGI is actively misusing individual consumer data, but it does mean that your genomic sequence data stored in a BGI system has a different legal protection architecture than data stored in a German or Korean lab.

The practical decision: BGI is appropriate for travelers who understand the data jurisdiction trade-off and are sequencing for research purposes where international data access is not a concern. It is a more complex choice for travelers sequencing for clinical health decisions who want maximum data control.

Cancer screening tourism 2026: Galleri, GRAIL, and full-body international options

What Makes Centogene Different, and Who Should Consider Germany?

Centogene, headquartered in Rostock, Germany, occupies a distinct tier in the international sequencing market: rare disease clinical diagnostics with the world's largest proprietary rare disease biobank.

Photo by National Cancer Institute on Unsplash

Pricing: Centogene's whole-genome sequencing for rare disease diagnostics runs approximately $1,200-$2,500 depending on the panel and the degree of clinical interpretation included. Gene panel testing for specific rare conditions is available at lower price points, often $300-$800 for targeted panels. Centogene is not a budget alternative to US sequencing; their value proposition is diagnostic accuracy for rare and ultra-rare conditions, not cost savings.

Who should consider Centogene: Patients and families dealing with undiagnosed rare diseases, congenital conditions, lysosomal storage disorders, or conditions where US labs have returned uninformative results. Centogene's proprietary rare disease biobank (one of the world's largest) enables variant interpretation against a rare disease-specific reference population that most general WGS labs cannot match.

GDPR and data protection: As a German-registered company, Centogene operates under the EU General Data Protection Regulation. Genomic data is subject to GDPR's special category protections for health data, including explicit consent requirements, right to erasure, and prohibition on data transfer to non-GDPR-compliant jurisdictions without explicit consent. This is the strongest regulatory data protection framework currently available for medical data internationally.

Clinical interpretation standard: Centogene's reports are produced in a clinical diagnostic framework and are written for physician interpretation. Their findings are actionable in the context of a European clinical system and can be shared with a US genetic counselor for secondary interpretation.

What Are the GINA Coverage Gaps You Actually Need to Understand?

GINA is the most misunderstood law in consumer genetic testing. A 2021 study published in Genetics in Medicine found that among people who reported high knowledge of GINA, over 92% incorrectly believed or did not know that GINA fails to protect them in life, disability, and long-term-care insurance contexts.

Photo by National Cancer Institute on Unsplash

What GINA covers: Title I of GINA prohibits health insurers (including employer-sponsored group plans) from using genetic information to set premiums, determine eligibility, or impose pre-existing condition exclusions. Title II prohibits employers with 15 or more employees from using genetic information in hiring, firing, pay, job assignments, or any other employment decisions.

What GINA does not cover: Life insurance. Disability insurance. Long-term-care insurance. These insurers are legally permitted under current federal law to request genetic test results as part of underwriting and to use those results in coverage and premium decisions. The National Human Genome Research Institute (NHGRI) states this directly:

"GINA does not cover life insurance, disability insurance, or long-term care insurance. These types of insurers may ask for genetic information and use it to make decisions about coverage."

Source: National Human Genome Research Institute, Genetic Discrimination, genome.gov

The international testing question: Testing with Macrogen or Centogene does not change this gap. If you disclose genetic results on a US life insurance application (as required by most application forms), the insurer can use those results regardless of which country produced the sequencing. The protection gap is structural, not geographic.

State-level protections: Several states have passed genomic privacy laws that extend beyond GINA. California's Confidentiality of Medical Information Act (CMIA) offers some additional protections. Florida, Texas, and Illinois have passed genetic data privacy laws with varying scope. These do not uniformly close the life/disability/LTC gap.

The practical decision: If you are planning to apply for life, disability, or long-term-care insurance in the next 2-5 years, consult a genetic counselor and an insurance attorney before banking positive results anywhere. Many genetic counselors recommend completing major insurance applications before pursuing broad WGS testing. This is equally true whether you test domestically or internationally.

Is International Sequencing Raw Data Usable by US Physicians?

This is the question most travel-focused genetic testing articles skip, and it is the most operationally important.

US physicians and genetic counselors who order or interpret genetic tests are trained to use ACMG variant classification standards. Results from international labs must be translated into this framework to be actionable in a US clinical context.

The American College of Medical Genetics and Genomics (ACMG) publishes the authoritative framework for variant classification in the US:

"The ACMG/AMP variant interpretation guidelines provide a standardized, evidence-based framework for classifying sequence variants across five categories: pathogenic, likely pathogenic, uncertain significance, likely benign, and benign."

Source: ACMG/AMP Standards and Guidelines for the Interpretation of Sequence Variants, American College of Medical Genetics and Genomics

Macrogen and Centogene both produce variant annotation that is compatible with ACMG classification frameworks. A US-licensed genetic counselor can typically review an international VCF file and annotated report from either lab and translate findings into ACMG-compatible clinical language. BGI results, also VCF-formatted, are compatible in principle but may require additional review given platform differences.

What this means in practice: Budget for a US genetic counselor interpretation session ($150-$400 per hour, sometimes covered by health insurance) as part of your total genetic testing travel cost. International sequencing plus US genetic counselor interpretation is still often cheaper than domestic WGS with full clinical interpretation.

How Do You Actually Plan a Genetic Testing Trip?

Most genetic testing travel does not require an in-person lab visit. Here is the practical structure for 2026.

Photo by National Cancer Institute on Unsplash

Option A: Mail-in from the US. Macrogen accepts international sample shipments. You order the kit, submit a saliva or blood sample via FedEx International, and receive results digitally. No travel required. This is the simplest path for WGS cost savings. The "travel" is the planning decision, not a physical trip.

Option B: In-person sample submission during another trip. If you are already traveling to Seoul, Berlin, or Hong Kong, you can arrange a blood draw at a local clinic and submit samples directly to the lab. This reduces international sample shipping time and is practical if you are already going for other reasons. Macrogen's Seoul headquarters facility offers clinical blood draw services. Centogene's German lab works with affiliated clinical collection sites across Europe.

Option C: Dedicated medical travel trip. For complex rare disease workups through Centogene, or for travelers who want in-person consultation with clinical geneticists, a dedicated trip to Germany or Korea is worth planning. This is typically for patients with undiagnosed conditions who have exhausted domestic diagnostic options. Travel Anywhere helps plan and book these trips, including coordinating with local clinical facilities and scheduling around lab appointment availability.

Logistics that matter:

• Sample stability: saliva (DNA) is stable at room temperature for 2-4 weeks; blood tubes have shorter windows and require specific shipping conditions
• Lab collection requirements: verify blood versus saliva versus buccal swab requirements before booking
• Customs documentation: some countries require customs declarations for biological samples in transit
• Report language: Macrogen and Centogene both produce English-language reports; BGI reports may require translation for some test types

Travel Anywhere is the AI-powered travel planning platform at travelanywhere.chat that helps readers plan trips around international genetic-testing labs (Macrogen Korea, BGI Hong Kong, Centogene Germany), coordinate sample logistics, and integrate genetic results into broader preventive-care travel planning.

FAQ

Is it legal for US citizens to mail DNA samples to international labs? Yes, in most cases. Sending saliva or blood samples for personal genetic testing is generally legal and not subject to FDA restriction for personal health purposes. Check the specific import/export regulations for the destination country and use a courier that handles biological specimen shipping. Macrogen and Centogene both have established international sample receipt protocols.

Does health insurance cover international genetic testing? Rarely. US health insurance typically covers genetic tests ordered by a US licensed physician through a CAP/CLIA-certified US laboratory. International sequencing is almost universally an out-of-pocket expense. However, a subsequent genetic counseling session with a US counselor to interpret international results may be covered by insurance if ordered through a physician.

What happened to Nebula Genomics? Nebula Genomics shut down its consumer whole-genome sequencing service on February 5, 2025. Their 30x and 100x WGS products are no longer available. Sequencing.com is the most direct successor in the US DTC WGS space, offering 30x WGS at comparable price points with raw data delivery.

Should I be worried about giving my DNA to a foreign government? This depends on the lab and your threat model. Germany's GDPR framework gives Centogene customers the strongest regulatory protections globally. Korea's PIPA framework (Macrogen) is considered GDPR-comparable. China's DSL/PIPL framework (BGI) creates different legal exposure to government data requests. If genomic data privacy is a primary concern, a German or Korean lab provides materially stronger regulatory protections than a Chinese-domiciled lab.

Do I need a doctor's order for international genetic testing? Most international labs offering consumer-facing research sequencing (Macrogen consumer, BGI research service) do not require a physician order. Centogene's clinical diagnostic tests typically require a referring physician or genetic counselor. For clinical-grade testing intended to inform medical decisions, a physician or genetic counselor involvement is strongly advisable regardless of the lab location.

What is a VCF file and do I need to understand it? A VCF (Variant Call Format) file is the raw machine output listing every position in your genome that differs from a reference sequence. It is not human-readable in raw form. Your genetic counselor or a genomics interpretation platform (such as Sequencing.com's analysis tools) converts VCF data into interpretable health reports. Ensuring you receive the raw VCF file is important because it lets you re-analyze with future tools as genomic science advances.

How do I find a US genetic counselor for international result interpretation? The National Society of Genetic Counselors (NSGC) maintains a searchable directory at nsgc.org. Telehealth genetic counseling has expanded significantly post-2020; many US-licensed genetic counselors offer video consultations and can review internationally obtained reports. Sessions typically run $150-$400 per hour; some insurers cover genetic counseling when ordered by a physician.

Medical tourism insurance 2026: which policies cover international complications

Sources

1. National Human Genome Research Institute (NHGRI): Genetic Discrimination: https://www.genome.gov/about-genomics/policy-issues/Genetic-Discrimination
2. US EEOC, GINA Guidance: https://www.eeoc.gov/statutes/genetic-information-nondiscrimination-act-2008
3. NIH Genetic Testing Registry, Centogene GmbH: https://www.ncbi.nlm.nih.gov/gtr/labs/279559/
4. Macrogen Europe, Whole Genome Sequencing: https://www.macrogen-europe.com/service/whole-genome-sequencing
5. BGI Genomics, Human WGS Services: https://www.bgi.com/us/sequencing-services/dna-sequencing/whole-genome-sequencing/
6. Centogene, Whole Genome Sequencing: https://www.centogene.com/diagnostics/our-tests/whole-genome-sequencing
7. Invitae (via Labcorp), Hereditary Cancer Testing: https://www.invitae.com/en/hereditary-cancer/
8. Color Health, Hereditary Cancer Screening: https://www.color.com/hereditary-cancer
9. American College of Medical Genetics and Genomics (ACMG), Variant Interpretation Standards: https://www.acmg.net/ACMG/Medical-Genetics-Practice-Resources/Practice-Guidelines.aspx
10. JAMA, Genetic Testing and Insurance Discrimination Review: https://jamanetwork.com/journals/jama/fullarticle/genetic-testing-insurance
11. PMC / Genetics in Medicine, GINA knowledge gaps study: https://pmc.ncbi.nlm.nih.gov/articles/PMC8633070/
12. PMC, GINA exclusions from disability, long-term care, life insurance: https://pmc.ncbi.nlm.nih.gov/articles/PMC6354179/
13. FDA, Genomics and Personalized Medicine Policy: https://www.fda.gov/science-research/science-and-research-special-topics/advancing-regulatory-science-genomics
14. National Society of Genetic Counselors (NSGC), Find a Counselor: https://www.nsgc.org/Find-a-Genetic-Counselor

---

Ready to make this trip happen? Travel Anywhere plans and books everything — start to finish. Begin at travelanywhere.chat.